Up-regulation of iNOS mRNA expression and increased production of NO in human monoblast cell line, U937 transfected by HTLV-I tax gene

Immunobiology

Volumn 197, Issue 5, 1997, Pages 513-521

  Goto, Hirofumi ^a   Nakamura, Tatsufumi ^a   Shirabe, Susumu ^a   Ueki, Yukitaka ^b   Nishiura, Yoshihiro ^a   Furuya, Takafumi ^a   Tsujino, Akira ^a   Nakane, Shunya ^a   Eguchi, Katsumi ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b SASEBO CHUO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TAX PROTEIN;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONOCYTE; MONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS GENE;

EID: 0030684159     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80083-6     Document Type: Article

References (29)

1. HINUMA, Y., K. NAGATA, M. HANAOKA, M. NAKAI, T. MATSUMOTO, K. KINOSHITA, S. SHIRAKAWA, and I. MIYOSHI. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78: 6476-6480.
2. OSAME, M., K. USUKU, S. IZUMO, N. IJICHI, H. AMITANI, A. IGATA, M. MATSUMOTO, and M. TARA. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
3. KOYANAGI, Y., Y. ITOMYAMA, N. NAKAMURA, K. TAKAMATSU, J. KIRA, T. IWAMASA, I. GOTO, and N. YAMAMOTO. 1993. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196: 25-33.
4. YAMADA, M., K. WATABE, T. SAIDA, and S. U. KIM. 1991. Increased susceptibility of human fetal astrocytes to human T-lymphotropic virus type I in culture. J. Neuropathol. Exp. Neurol. 50:97-107.
5. NAKAJIMA, T., H. AONO, T. HASUNUMA, K. YAMAMOTO, I. MARUYAMA, T. NOSAKA, M. HATANAKA, and K. NISHIOKA. 1993. Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene. J. Clin. Invest. 92: 186-193.
6. MONCADA, S., R. M. J. PALMER, and E. A. HIGGS. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142.
7. HIBBS, J. B. Jr., R. R. TAINTOR, Z. VAVRIN, and E. M. RACHLIN. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94.
8. KANETO, H., J. FUJII, H. G. SEO, K. SUZUKI, T. MATSUOKA, M. NAKAMURA, H. TATSUMI, Y. YAMASAKI, T. KAMADA, and N. TANIGUCHI. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44: 733-738.
9. FARRELL, A. J., D. R. BLAKE, R. M. J. PALMER, and S. MONCADA. 1992. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51: 1219-1222.
10. BUKRINSKY, M. I., H. S. L. M. NOTTET, H. SCHMIDTMAYEROVA, L. DUBROVSKY, C. R. FLANAGAN, M. E. MULLINS, S. A. LIPTON, and H. E. GENDELMAN. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181: 735-745.
11. SUNDSTRÖM, C., and K. NILSSON. 1976. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577.
12. FUJISAWA, J., M. TOITA, T. YOSHIMURA, and M. YOSHIDA. 1991. The indirect association of human T-cell leukemia virus tax protein with DNA results in transcriptional activation. J. Virol. 65: 4525-4528.
13. FELGNER, P. L., T. R. GADEK, M. HOLM, R. ROMAN, H. W. CHAN, M. WENZ, J. P. NORTHROP, G. M. RINGOLD, and M. DANIELSEN. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procdure. Proc. Natl. Acad. Sci. USA 84: 7413-7417.
14. MELBY, P. C., B. J. DARNELL, and V. V. TRYON. 1993. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J. Immunol. Methods 159: 235-244.
15. PALMER, R. M. J., A. G. FERRIGE, and S. MONCADA. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
16. UEKI, Y., S. MIYAKE, Y. TOMINAGA, and K. EGUCHI. 1996. Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23: 230-236.
17. x and T3/Ti complex triggering. Cell 48: 343-350.
18. BALLARD, D. W., E. BÖHNLEIN, J. W. LOWENTHAL, Y. WANO, B. R. FRANZA, and W. C. GREENE. 1988. HTLV-1 Tax induces cellular proteins that activate the κB element in the IL-2 receptor α gene. Science 241: 1652-1655.
19. x protein activate the mouse granuocytemacrophage colony-stimulating factor gene through a common DNA element. Mol. Cell. Biol. 8: 5581-5587.
20. VILLIGER, P. M., M. T. CRONIN, T. AMENOMORI, W. WACHSMAN, and M. LOTZ. 1991. IL-6 production by human T lymphocytes expression in HTLV-1-infected but not in normal T cells. J. Immunol. 146: 550-559.
21. LINDHOLM, P. F., R. L. REID, and J. N. BRADY. 1992. Extracellular Tax, protein stimulates tumor necrosis factor-β and immunoglobulin kappa light chain expression in lymphoid cells. J. Virol. 66: 1294-1302.
22. DURAND, D. B., J. P. SHAW, M. R. BUSH, R. E. REPLOGLE, R. BELAGAJE, and G. R. CRABTREE. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8: 1715-1724.
23. NUNOKAWA, Y., S. OIKAWA, and S. TANAKA. 1996. Human inducible nitric oxide syntnase gene is transcriptionally regulated by nuclear factor-κB dependent mechanism. Biochem. Biophys. Res. Commun. 223: 347-352.
24. SILVENNOINEN, O., J. N. IHLE, J. SCHLESSINGER, and D. E. LEVY. 1993. Interferon-induced nuclear signalling by jak protein tyrosine kinases. Nature 366: 583-585.
25. NISHIYA, T., T. UEHARA, and Y. NOMURA. 1995. Herbimycin A suppresses NF-κB activation and tyrosine phosphorylation of JAK2 and the subsequent induction of nitric oxide synthase in C6 glioma cells. FEBS Lett. 371: 333-336.
26. Xu, X., S. KANG, O. HEIDENREICH, M. OKERHOLM, J. J. O'SHEA, and M. I. NERENBERG. 1995. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J. Clin. Invest. 96: 1548-1555.
27. AKIZUKI, S., O. NAKAZATO, Y. HIGUCHI, K. TANABE, M. SETOGUCHI, S. YOSHIDA, Y. MIYAZAKI, S. YAMAMOTO, S. SUDOU, K. SANNOMIYA, and T. OKAJIMA. 1987. Necropsy findings in HTLV-I associated myelopathy. Lancet 1: 156-157.
28. ISHIGURO, N., M. ABE, K. SETO, H. SAKURAI, H. IKEDA, A. WAKISAKA, T. TOGASHI, M. TATENO, and T. YOSHIKI. 1992. A rat model of human T lymphocyte virus type I (HTLV-I) infection. 1. Humoral antibody response, provirus integration, and HTLV-I associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. Exp. Med. 176: 981-989.
29. IWASAKI, Y., S. AKIZUKI, and M. MIWA. 1994. Role of monocyte/macrophage lineage cells in HAM/TSP. Ann. N. Y. Acad. Sci. 724:414-416.